These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 6127330)

  • 21. [Clinical and metabolic effects of metipranolol].
    Cottini E; Barbanti P; Lunetta M; Dimaiuta G; Emma V; Sorrentino F
    Boll Soc Ital Cardiol; 1981; 26(10):1341-8. PubMed ID: 6129875
    [No Abstract]   [Full Text] [Related]  

  • 22. Aspirin in coronary heart disease. The Coronary Drug Project Research Group.
    Circulation; 1980 Dec; 62(6 Pt 2):V59-62. PubMed ID: 7002353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary and secondary prevention of myocardial infarction and strokes: an update of randomly allocated, controlled trials.
    Yusuf S; Lessem J; Jha P; Lonn E
    J Hypertens Suppl; 1993 Jun; 11(4):S61-73. PubMed ID: 8104243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The concept of beta-adrenoreceptor blockade in the primary and secondary prevention of cardiac mortality and morbidity.
    Bühler FR; Bolli P
    Triangle; 1980; 19(1):35-45. PubMed ID: 6109387
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of nadolol in coronary disease].
    Tkaczewski W; Goch JH; Dziekański S
    Kardiol Pol; 1983; 26(3):215-9. PubMed ID: 6138456
    [No Abstract]   [Full Text] [Related]  

  • 26. [Characteristics of patients with coronary disease and aspirin prescription in Haute-Garonne].
    Cambou JP; Lablache-Combier B; Marques-Vidal P; Ruidavets JB; Branchu MP; Ferrières J
    Ann Cardiol Angeiol (Paris); 1994 Dec; 43(10):588-93. PubMed ID: 7864551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical experiences with a combined preparation (butydrine and pentaerythritol tetranitrate) in coronary insufficiency].
    Chiti E
    Clin Ter; 1970 May; 53(4):315-21. PubMed ID: 4394192
    [No Abstract]   [Full Text] [Related]  

  • 28. Future possibilities for conducting clinical trials to test the efficacy of beta-blocker medications.
    Naughton J
    Circulation; 1983 Jun; 67(6 Pt 2):I106-9. PubMed ID: 6133639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of beta-adrenergic blocking agents after myocardial infarction.
    Talbert RL
    Clin Pharm; 1983; 2(1):68-74. PubMed ID: 6136362
    [No Abstract]   [Full Text] [Related]  

  • 30. Aspirin and secondary mortality after myocardial infarction.
    Elwood PC; Sweetnam PM
    Circulation; 1980 Dec; 62(6 Pt 2):V53-8. PubMed ID: 7438381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study.
    Eagle KA; Kline-Rogers E; Goodman SG; Gurfinkel EP; Avezum A; Flather MD; Granger CB; Erickson S; White K; Steg PG
    Am J Med; 2004 Jul; 117(2):73-81. PubMed ID: 15234641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myocardial infarction in the 1990s. The importance of early thrombolytic therapy.
    Fowles RE
    Postgrad Med; 1995 May; 97(5):135-8, 141-2, 145-6. PubMed ID: 7753739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical impressions of a new beta-adrenergic blocking drug, 39,089-Ba.
    Wilson DF; Turner AS
    N Z Med J; 1967 Oct; 66(422):682-3. PubMed ID: 4864443
    [No Abstract]   [Full Text] [Related]  

  • 34. ACE inhibitors in acute myocardial infarction.
    Murdoch DR; McMurray JJ
    Hosp Med; 1998 Feb; 59(2):111-5. PubMed ID: 9797884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Results of ambulatory follow-up of patients after myocardial infarction treated with platelet aggregation inhibitors and antithrombotic drugs].
    Markiewicz M; Rymar B; Florkiewicz H; Wysokiński A
    Pol Tyg Lek; 1983 Nov; 38(48):1501-3. PubMed ID: 6382203
    [No Abstract]   [Full Text] [Related]  

  • 36. Dialogue with a patient with coronary artery disease.
    Salomon F
    Schweiz Med Wochenschr; 1999 Nov; 129(45):1697-700. PubMed ID: 10595379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of outcomes in acute coronary syndrome in patients receiving statins within 24 hours of onset versus at later times.
    Saab FA; Eagle KA; Kline-Rogers E; Fang J; Otten R; Mukherjee D;
    Am J Cardiol; 2004 Nov; 94(9):1166-8. PubMed ID: 15518612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aspirin and ischaemic heart disease.
    Br J Hosp Med; 1986 Aug; 36(2):85. PubMed ID: 3527318
    [No Abstract]   [Full Text] [Related]  

  • 39. [Relationship between mortality due to acute myocardial infarction and adherence to clinical guidelines].
    Coma-Canella I
    Rev Esp Cardiol; 2006 Mar; 59(3):189-92. PubMed ID: 16712740
    [No Abstract]   [Full Text] [Related]  

  • 40. Beta-adrenergic blockade after myocardial infarction: clinical and public health implications of the reported beta-blocker clinical trials.
    Friedewald WT
    Circulation; 1983 Jun; 67(6 Pt 2):I110-1. PubMed ID: 6133641
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.